Aytu BioPharma (STU:AY20) Change In Other Working Capital : €-0.90 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aytu BioPharma Change In Other Working Capital?

Aytu BioPharma's Change In Other Working Capital for the quarter that ended in Sep. 2024 was €0.04 Mil. It means Aytu BioPharma's Other Working Capital increased by €0.04 Mil from Jun. 2024 to Sep. 2024 .

Aytu BioPharma's Change In Other Working Capital for the fiscal year that ended in Jun. 2024 was €3.57 Mil. It means Aytu BioPharma's Other Working Capital increased by €3.57 Mil from Jun. 2023 to Jun. 2024 .

Aytu BioPharma Change In Other Working Capital Historical Data

The historical data trend for Aytu BioPharma's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aytu BioPharma Change In Other Working Capital Chart

Aytu BioPharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Other Working Capital

Get a 7-Day Free Trial

-0.28

0.05

-1.73

3.57

Aytu BioPharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Other Working Capital	Get a 7-Day Free Trial															4.56	-0.93	0.04	-0.04	0.04

Aytu BioPharma Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.90 Mil.

Aytu BioPharma Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Aytu BioPharma's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Aytu BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aytu BioPharma Inc (STU:AY20) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

AYTU:USA 0A8M:UK

Address

7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237

Website

https://www.aytubio.com

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Aytu BioPharma Headlines

No Headlines